Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Columbia University |
---|---|
Information provided by: | Columbia University |
ClinicalTrials.gov Identifier: | NCT00624793 |
The subjects in this research study will be 159 men and women with HIV infection who have a history of chronic nausea for three months or greater and show evidence of two or more episodes of nausea and/or report a duration of two hours or more (per day) in baseline symptom diaries. Subjects will be randomized (by chance) to one of three conditions: Condition 1, subjects receive Standard acupuncture (active treatment); Condition 2, subjects receive Individualized acupuncture based on Traditional Chinese Medical Diagnosis (active treatment); Condition 3, (Control Group), subjects receive Sham acupuncture. Subjects in Conditions 1, 2, & 3 will attend scheduled sessions over 24 weeks.
Condition | Intervention | Phase |
---|---|---|
HIV Infections |
Other: Acupuncture Other: Individualized Acup based on TCM diagnosis Other: Sham Acup |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment, Efficacy Study |
Official Title: | Acup for Chronic Nausea in HIV: A RCT |
Estimated Enrollment: | 159 |
Study Start Date: | May 2005 |
Estimated Study Completion Date: | February 2009 |
Estimated Primary Completion Date: | February 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
I. Standard: Experimental
Standard - Formula Acup Protocol
|
Other: Acupuncture
Standard Acup point protocol for treating nausea
|
2. Individualized: Experimental
Individualized Acup protocol based on TCM diagnosis
|
Other: Individualized Acup based on TCM diagnosis
Acup
|
3: Sham Comparator
(Control Group) Sham acupuncture
|
Other: Sham Acup
Sham Acup - Non-Active
|
The subjects in the proposed experiment will be 159 men and women with HIV infection who have a history of chronic nausea for three months or greater and show evidence of two or more episodes of nausea and/or report a duration of 2 hours or greater (per day) in prospective baseline symptom diaries. Subjects will be randomized to one of three experimental intervention conditions: Condition 1, subjects receive Standard acupuncture; Condition 2, subjects receive Individualized acupuncture based on Traditional Chinese Medical Diagnosis; Condition 3, (Control Group), subjects receive Sham acupuncture. Subjects in Conditions 1, 2, & 3 will attend 16 scheduled sessions over 24 weeks. All subjects will: be assessed by a diagnostic acupuncturist (blinded to treatment assignments); be administered the same instruments; and submit their symptom diaries for data entry and analysis. After a screening/intake session, randomization and treatment sessions will follow. There will be four weeks of twice weekly treatment sessions, four weekly treatment sessions and three follow-up sessions. All conditions will be identical in duration and be administered by licensed acupuncturists trained in Traditional Chinese Medicine. This study is a prospective, randomized, controlled, blinded (subject and evaluator), parallel groups clinical trial aimed at reducing chronic nausea and improving quality of life in persons with HIV/AIDS.
Ages Eligible for Study: | 18 Years to 70 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Ann M Chung | 212-305-3041 | amc103@columbia.edu |
Contact: Colin Scully | 212-305-3041 |
United States, New York | |
Center for AIDS Research (CFAR): Columbia University School of Nursing | Recruiting |
New York, New York, United States, 10032 | |
Contact: Ann M Chung 212-305-3041 | |
Contact: Colin Scully 212-305-3041 | |
Principal Investigator: Joyce K Anastasi, PhD |
Principal Investigator: | Joyce K Anastasi, PhD | Columbia University |
Responsible Party: | Columbia University School of Nursing ( Joyce K. Anastasi, PhD ) |
Study ID Numbers: | AAAA9068 |
Study First Received: | February 19, 2008 |
Last Updated: | March 19, 2008 |
ClinicalTrials.gov Identifier: | NCT00624793 |
Health Authority: | United States: Institutional Review Board |
Nausea Vomiting Retching |
HIV/AIDS Symptom Management Complementary Therapies |
Virus Diseases Sexually Transmitted Diseases, Viral Vomiting HIV Infections Sexually Transmitted Diseases |
Acquired Immunodeficiency Syndrome Nausea Retroviridae Infections Immunologic Deficiency Syndromes |
RNA Virus Infections Slow Virus Diseases Immune System Diseases Lentivirus Infections Infection |